American Indians have arrived at a critical point in their more than 500-year history with the United States Government. With the advent of the new bio-revolution, a number of tribes have voiced vehement opposition to genetic patenting, creation of cell lines, transgenic experimentation and cloning. While many are opposed to the Human Genome Diversity Project, Human Genome Project and diversity research currently being conducted by the Indian Health Service, a few embrace the beneficial aspects of biomedical/biogenetic research. Moreover, an increasing number of Indians see the need for and are seeking genetic counseling and other services. This paper briefly describes some of the issues associated with developing and implementing effective genetic services within Native American communities. Problems of access, perception of services, previous experience with genetics and cultural and other barriers are discussed. Recommendations also are rendered to assist health professionals in the development of services.

Keywords:
Native Americans, Alaskan natives, Minority, Tribe, Access, Human genome, Diversity, Culture
1.
Department of Commerce, Bureau of the Census: General Population Characteristics, 1990 Census. Washington, Government Printing Office, 1992.
2.
Utter J: American Indians – Answers to Today’s Question. Michigan, National Woodlands Publishing Company, 1993, p 39.
3.
The National Congress of American Indians, Resolution No SFE-97-042. Title: US Abrogation or Violation of Indian Treaties via Bio-Diversity Convention.
4.
US Department of Commerce, Economics and Statistics Administration, Bureau of the Census: We the First Americans. Washington, US Government Printing Office, 1993, Publ No 350-631, pp 6, 10.
5.
Department of Commerce, Bureau of the Census: Selected social and economic characteristics by race and Hispanic origin for the United States. American Indian population by tribe for the United States, regions, division, and states: 1990, CPH-L-99. Washington, Government Printing Office, 1992.
6.
Trends in Indian Health: Rockville, US Department of Health and Human Services, Indian Health Service, 1996.
7.
Dukepoo FC: Commentary on ‘Scientific limitations and ethical ramifications of non-representative Human Genome Project: African American Responses’ An American Indian Perspective. Sci Eng Ethics 1998;4:171–180.
8.
Dukepoo FC: The trouble with the human Genome Diversity Project. Mol Med Today 1998;4:242–243.
9.
Dukepoo FC: Native American perspectives on genetic patenting; in ‘Religion, Science and Industry in Dialogue’. American Association for the Advancement of Science, in press.
10.
Collins FS, Guyer MS, Chakravarti A: Variation on a theme: Cataloging human DNA sequence variation. Science 1997;278:1580–1581.
11.
Smithson S: Breaking cultural taboos to save lives. Arizona Daily Sun, August 30, 1998.
12.
Burhansstipanov L, Tenny M: Native American health issue. Curr Issues Public Health 1995;1:35–41.
13.
Marin G, et al: A research agenda for health education among under-served populations. Health Educ Q 1995;22:346–363.
14.
Developing Effective Cancer Education Print Materials for Native Americans. Dallas, Susan G. Komen Breast Cancer Foundation, 1997.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.